InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.270 0.02 (0.87%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$423 Update - Notification of buy-back - ACL 11 May 2026 9:24AM $1.920 $2.270 risen by 18.23%
$423 Ceasing to be a substantial holder 8 May 2026 8:11AM $1.910 $2.270 risen by 18.85%
$423 Update - Notification of buy-back - ACL 7 May 2026 8:21AM $1.910 $2.270 risen by 18.85%
$423 Update - Notification of buy-back - ACL 5 May 2026 10:06AM $1.925 $2.270 risen by 17.92%
$423 Ceasing to be a substantial holder from MQG 4 May 2026 4:52PM $1.920 $2.270 risen by 18.23%
$423 Update - Notification of buy-back - ACL 1 May 2026 9:42AM $1.890 $2.270 risen by 20.11%
$423 External IT service provider cyber incident - SunDoctors 30 Apr 2026 8:34AM $1.910 $2.270 risen by 18.85%
$423 Becoming a substantial holder from MQG 27 Apr 2026 3:16PM $1.930 $2.270 risen by 17.62%
$423 Change in substantial holding 23 Apr 2026 5:18PM $1.960 $2.270 risen by 15.82%
$423 Notification of cessation of securities - ACL 23 Apr 2026 1:41PM $1.950 $2.270 risen by 16.41%
$423 Class action proceedings 21 Apr 2026 8:14AM $2.090 $2.270 risen by 8.61%
$423 Ceasing to be a substantial holder 17 Apr 2026 2:18PM $2.075 $2.270 risen by 9.40%
$423 Update - Notification of buy-back - ACL 17 Apr 2026 11:49AM $2.075 $2.270 risen by 9.40%
$423 Change in substantial holding 16 Apr 2026 4:03PM $2.090 $2.270 risen by 8.61%
$423 Becoming a substantial holder 16 Apr 2026 2:37PM $2.085 $2.270 risen by 8.87%
$423 Notification of cessation of securities - ACL 16 Apr 2026 10:22AM $2.080 $2.270 risen by 9.13%
$423 Update - Notification of buy-back - ACL 16 Apr 2026 10:17AM $2.055 $2.270 risen by 10.46%
$423 Update - Notification of buy-back - ACL 15 Apr 2026 10:34AM $2.035 $2.270 risen by 11.55%
$423 Update - Notification of buy-back - ACL 14 Apr 2026 10:56AM $2.035 $2.270 risen by 11.55%
$423 Notification of cessation of securities - ACL 14 Apr 2026 10:50AM $2.035 $2.270 risen by 11.55%
$423 Update - Notification of buy-back - ACL 13 Apr 2026 5:23PM $2.020 $2.270 risen by 12.38%
$423 Update - Notification of buy-back - ACL 13 Apr 2026 2:28PM $2.045 $2.270 risen by 11%
$423 Notification of cessation of securities - ACL 10 Apr 2026 4:31PM $2.070 $2.270 risen by 9.66%
$423 Update - Notification of buy-back - ACL 10 Apr 2026 2:12PM $2.050 $2.270 risen by 10.73%
$423 Update - Notification of buy-back - ACL 9 Apr 2026 11:31AM $2.080 $2.270 risen by 9.13%

26 - 50 of 999 results

Page 2 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.